FIELD: medicine; pharmaceuticals.
SUBSTANCE: present invention relates to a pharmaceutical composition for treating non-alcoholic fatty liver disease and a method for production thereof. Described is a pharmaceutical composition for treating non-alcoholic fatty liver disease, which is obtained from the following medicinal raw materials: 26.25 to 180 g of silybin, 45 to 195 g of phospholipid, 75 to 600 g of Pu'er tea extract and 7.5 to 150 g extract of Radix puerariae.
EFFECT: technical result is preventive and therapeutic effect with respect to non-alcoholic fatty liver disease.
22 cl, 23 ex, 6 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN | 2016 |
|
RU2697523C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN AND VITAMIN E | 2016 |
|
RU2695806C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN AND L-CARNITINE | 2016 |
|
RU2699011C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN, VITAMIN E AND L-CARNITINE | 2016 |
|
RU2700793C2 |
| PHARMACEUTICAL COMBINATION CONTAINING SILYBIN | 2016 |
|
RU2695224C2 |
| USE OF PEGYLATED RECOMBINANT CHIMERIC MOUSE FIBROBLAST-21 GROWTH FACTOR OR ITS PHARMACEUTICALLY ACCEPTABLE SALT IN COMPOSITION OF DRUGS FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | 2018 |
|
RU2785582C2 |
| USE OF POLYDATINE FOR TREATING HEPATIC DISEASES AND POLYDATINE PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2468803C2 |
| NEW MILK THISTLE EXTRACT, METHOD FOR PREPARING AND USING IT | 2008 |
|
RU2489161C2 |
| COMPOSITION FOR PREVENTING OR TREATING FATTY LIVER DISEASES | 2015 |
|
RU2664696C2 |
| NOVEL COMPOUNDS WITH SPIROCHIRAL CARBON BASE, METHODS OF THEIR OBTAINING AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN SUCH COMPOUNDS | 2009 |
|
RU2492173C2 |
